Skip to content
H
Unlocking infinite medical capacity.
PageHeaderNews2
Latest announcements

Harrison.ai Named on the 2022 CB Insights’ Digital Health 150 List

The clinician-led technology platform has been recognized for achievements in computer-aided imaging.

NEW YORK, December 7, 2022CB Insights today named harrison.ai to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022.

“From reimagining clinical care, to leveraging tech like AR/VR to improve surgical training, this year’s Digital Health 150 winners are transforming the future of healthcare with digital technology,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s winners.”

Copy-of-DH150_2022_social_nologo-e1670449570916

Dimitry Tran, Harrison.ai’s Co-Founder and Chief Business Development Officer said “It’s an honour for Harrison.ai to be recognised by CB Insights as one of the 150 most innovative digital health companies globally. We’re thrilled to be listed alongside a number of leading global health-focused businesses that are committed to transforming healthcare, this is a true testament to our industry and an acknowledgment of the impact we are making. Along with the team at Harrison.ai, we are committed to our mission to raise the standard of healthcare for millions of patients every day and continue to make our vision a reality by redefining what’s possible in healthcare through AI technology.”

Utilizing the CB Insights platform, the research team selected these 150 winners from a pool of over 13,000 private companies, including applicants and nominees. They were chosen based on factors including R&D activity, proprietary Mosaic scores, market potential, ebusinss relationships, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty. The research team also reviewed over 3,000 Analyst Briefings submitted by applicants.

Copy-of-Digital-Health-150-MM-120522-V1-UPDATED-e1670449380196

With a vision to redefine what’s possible in healthcare through AI technology, Harrison.ai works with ventures to develop, commercialise and deploy AI tools that support clinical diagnosis.

In 2019, Harrison.ai created its first joint venture with I-MED Radiology, Annalise.ai, creating the world’s most comprehensive AI clinical decision-support solutions for diagnostic imaging. Most recently, Annalise.ai released next-generation CT Brain AI solution for clinical use in Australia, New Zealand and the UK. In 2021, Harrison.ai partnered with Sonic Healthcare to put AI tools in the hands of pathologists with Franklin.ai.

This year alone, Harrison.ai has launched a gender-neutral policy for new parents, was awarded Best New Radiology Solution at the Medtech Breakthrough Awards, won the 2022’s Best New Radiology Vendor in the The Minnies Awards by AuntMinnie.com, and has been selected as an ABA100® Winner for HR Management in The Australian Business Awards 2022.

Quick facts on the 2022 Digital Health 150: 

  • Equity funding and deals: Since 2017, this year’s Digital Health 150 winners have raised around $5.6B in equity funding across 378 deals. This includes approximately $1.6B raised across 85 deals in 2022 YTD alone.
  • Unicorns: This year’s list includes only 5 unicorns with a $1B+ valuation, around 3% of the total list. For comparison, last year’s list contained 17. This tracks with a broader drop in new unicorns across sectors in 2022
  • Global Reach: Winners in this year’s Digital Health 150 span 18 countries across 5 continents. A quarter (25%) are headquartered outside of the US — the most in the history of our list. While the US still leads, the UK comes in second with 9 winners, followed by Canada with 5 and Brazil with 3.

 

About CB Insights

CB Insights builds software that enables the world’s best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. To learn more, please visit www.cbinsights.com.
Contact: chris.orlando@cbinsights.com

About Harrison.ai

Harrison.ai is a clinician-led technology platform combining human intelligence with artificial intelligence (AI), building a range of ventures to change the face of healthcare and benefit millions of patients every day.

About Harrison.ai

Harrison.ai is a global healthcare technology company on a mission to urgently scale healthcare capacity through AI-powered medical imaging diagnostic support and workflow solutions. Its radiology (Annalise.ai) and pathology (Franklin.ai) solutions help clinicians deliver faster, more accurate diagnoses, aiding in the early detection of cancer and other medical conditions. Harrison.ai partners with hospitals and private clinics across APAC, EMEA, the United Kingdom and United States. For more information, visit Harrison.ai.

More news from Harrison.ai

AI ‘co-pilot’ used to speed up cancer diagnosis

AI software has been introduced by a West Yorkshire NHS Trust in a bid to speed up diagnosis of conditions such as lung cancer and infections.

Hospital uses AI technology to detect lung cancer

A North Yorkshire hospital has introduced AI technology that could speed up the detection of lung cancer and other serious illnesses.

Med-tech Harrison.ai’s new genAI tool outperforms OpenAI, Gemini

Australian medical technology company Harrison.ai has launched a radiology-specific generative AI model – and it’s already scoring higher than OpenAI and Gemini.

Ready to unlock infinite medical possibility?